The dimethylhydrazine induced colorectal tumours in rat - Experimental colorectal carcinogenesis

Radiology and Oncology

Volumn 39, Issue 1, 2005, Pages

  Perše, Martina ^a   Cerar, Anton ^a  

^a INSTITUTE OF PATHOLOGY   (Slovenia)

Author keywords

1,2 dimethylhydrazine; Azoxymethane; Colorectal neoplasms chemically induced; Disease models, animal; Rats

Indexed keywords

DIMETHYLHYDRAZINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CARCINOGENESIS; CHEMOPROPHYLAXIS; COLON CARCINOGENESIS; COLORECTAL CANCER; COLORECTAL TUMOR; CONTROLLED STUDY; DISEASE MODEL; EPITHELIUM TUMOR; EXPERIMENTAL NEOPLASM; GENETIC ANALYSIS; MEDICAL RESEARCH; MORPHOLOGICAL ADAPTATION; NONHUMAN; RAT; REVIEW; RISK FACTOR;

EID: 17144375293     PISSN: 13182099     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Nigro ND, Bull AW. Experimental intestinal carcinogenesis. Br J Surg 1985; S36-S41.
2. Shinchi N, Isamu K. Morphogenesis of experimental colonic neoplasms induced by dimethylhydrazine. In: Pfeiffer CJ, editor. Animal models for intestinal disease. Boca Raton, Florida: CRC Press Inc.; 1985. p. 99-121.
3. Maskens AP, Dujardin-Loits RM. Experimental adenomas and carcinomas of the large intestine behave as distinct entities: most carcinomas arise de novo in flat mucosa. Cancer 1981; 47: 81-9.
4. Shirai T, Nakanowatari J, Kurata Y, Fukushima S, Ito N. Different dose-response relationships in the induction of different types of colonic tumors in Wistar rats by 1,2-dimethylhydrazine. Gann 1983; 74: 21-7.
5. Tatematsu M, Imaida K. Tumours of the small intestine. In: Stinson SF, Schuller HM, Reznik GK, editors. Atlas of tumorpathology of the Fischer rat, Boca Raton, Florida: CRC Press Inc., 2000. p.117-32.
6. Elsayed AM, Shamsuddin AM. Neoplasms of the colon. In: Stinson SF, Schuller HM, Reznik GK, editors. Atlas of tumorpathology of the Fischer rat, Boca Raton, Florida: CRC Press Inc., 2000. p.133-91.
7. Sunter JP, Appleton DR, Wright NA, Watson AJ. Pathological feature of the colonic tumours induced in rats by the administration of 1,2-dimethylhydrazine. Virchows Arch B Cell Pathol 1978; 29: 211-23.
8. Veceric Z, Cerar A. Comparison of wistar vs. fischer rat in the incidence of 1,2-dimethylhydrazine induced intestinal tumours. Radiol Oncol 2004; 38: 227-34.
9. Pollard M, Zedeck MS. Induction of colon tumors in 1,2-dimethylhydrazine- resistant Lobund Wistar rats by methylazoxymethanol acetate. J Natl Cancer Inst 1978; 61: 493-4.
10. Kobaek-Larsen M, Fenger C, Hansen K, Nissen I, Diederichsen A, Thorup I, et al. Comparative study of histopathologic characterization of azoxymethane-induced colon tumors in three inbred rat strains. Comp Med 2002; 52: 50-7.
11. Breskvar L, Cerar A. A role of gender in the occurrence of dimethylhydrazine induced colorectal tumors in Wistar rats. Radiol Oncol 1997; 31: 374-9.
12. Izbicki JR, Wambach G, Hamilton SR, Harnisch E, Hogenschurz R, Izbicki W, et al. Androgen receptors in experimentally induced colon carcinogenesis. J Cancer Res Clin Oncol 1986; 112: 39-46.
13. Fiala ES, Sohn OS, Puz C, Czerniak R. Differential effects of 4-iodopyrazole and 3-methylpyrazole on the metabolic activation of methylazoxymethanol to a DNA-methylating species by rat liver and rat colon mucosa in vivo. J Cancer Res Clin Oncol 1987; 118: 145-50.
14. Rubio CA, Nylander G, Santos M. Experimental colon cancer in the absence of intestinal contents in Sprague-Dawley rats. J Natl Cancer Inst 1980; 64: 569-72.
15. Glauert HP, Bennink MR. Metabolism of 1,2-dimethylhydrazine by cultured rat colon epithelial cells. Nutr Cancer 1983; 5: 78-86.
16. Oravec CT, Jones CA, Huberman E. Activation of the colon carcinogen 1,2-dimethylhydrazine in a rat colon cell-mediated mutagenesis assay. Cancer Res 1986; 46: 5068-71.
17. Onoue M, Kado S, Sakaitani Y, Uchida K, Morotomi M. Specific species of intestinal bacteria influence the induction of aberrant crypt foci by 1,2-dimethylhydrazine in rats. Cancer Lett 1997; 113: 179-86.
18. Goldin BR, Gorbach SL. Effect of antibiotics on incidence of rat intestinal tumors induced by 1,2-dimethylhydrazine dihydrochloride. J Natl Cancer Inst 1981; 67: 877-80.
19. Narahara H, Tatsuta M, Lishi H, Baba M, Uedo N, Sakai N, et al. K-ras point mutation is associated with enhancement by deoxycholic acid of colon carcinogenesis induced by azoxymethane, but not with its attenuation by all-trans-retinoic acid. Int J Cancer 2000; 15: 157-61.
20. Swenberg JA, Cooper HK, Bucheler J, Kleihues P. 1,2 Dimethylhydrazine induced methylation of DNA bases in various rat organs and the effects of pre-treatment with disulfiram. Cancer Res 1979; 39: 465-7.
21. Boffa LC, Gruss RJ, Allfrey VG. Aberrant and non-random methylation of chromosomal DNA-binding proteins of colonic epithelial cells by 1,2-dimethylhydrazine. Cancer Res 1982; 42: 382-8.
22. Gennaro AR, Villanueva R, Sukonthaman Y, Vathanophas V, Rosemond GP. Chemical carcinogenesis in transported intestinal segments. Cancer Res 1973; 33: 536-41.
23. McGarrity TJ, Peiffer LP, Colony PC. Cellular proliferation in proximal and distal rat colon during 1,2-dimethylhydrazine-induced carcinogenesis. Gastroenterology 1988; 95: 343-8.
24. Park HS, Goodlad RA, Wright NA. The incidence of aberrant crypt foci and colonic carcinoma in dimethylhydrazine-treated rats varies in a site-specific manner and depends on tumor histology. Cancer Res 1997; 57: 4507-10.
25. Ravnik-Glavac M, Cerar A, Glavac D. Animal model in the study of colorectal carcinogenesis. Pflugers Arch 2000; 440 (Suppl5): R55-7.
26. Perse M, Zebic A, Cerar A. Rofecoxib does not inhibit aberrant crypt foci formation but inhibits later steps in the development of experimental colorectal cancer. Rofecoxib in experimental colon cancer. Scan J Gastroenterol 2005; 40: 61-7.
27. Ward JM, Yamamoto RS, Brown CA. Pathology of intestinal neoplasms and other lesions in rats exposed to azoxymethane. J Natl Cancer Inst 1973; 51: 1029-39.
28. Shetye J, Mathiesen T, Fagerberg J, Rubio C. Ear tumours induced by experimental carcinogenesis in the rat: excision prevents early death. Int J Colorectal Dis 1994; 9: 125-7.
29. Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 1987; 37: 147-51.
30. Bird RP, Good CK. The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicology Letters 2000; 112: 395-402.
31. Bird RP. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Letters 1995; 93: 55-71.
32. Rodrigues MA, Suva LA, Salvadori DM, De Camargo JL, Montenegro MR. Aberrant crypt foci and colon cancer: comparison between a short- and medium-term bioassay for colon carcinogenesis using dimethylhydrazine in Wistar rats. Braz J Med Biol Res 2002; 35: 351-5.
33. Shipitz B, Bomstein Y, Mekori Y, Cohen R, Kaufman Z, Neufeld D, et al. Aberrant crypt foci in human colons: distribution and histomorphologic characteristics. Hum Pathol 1998; 29: 469-75.
34. Cheng L, Lai MD. Aberrant crypt foci as microscopic precursors of colorectal cancer. World J Gastroenterol 2003; 9: 2642-9.
35. Rubio CA, Shetye J, Jaramillo E. Non-polypoid adenomas of the colon are associated with subjacent lymphoid nodules. Scand J Gastroenterol 1999; 34: 504-8.
36. Hamilton SR, Vogelstein B, Kudo S, Riboli E, Nakamura S, Hainaut P, et al. Carcinoma of the colon and rectum. In: Hamilton SR, Aaltonen LA, editors. WHO Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press; 2000. p. 103-113.
37. Cerar A, Zidar N, Vodopivec B. Colorectal carcinoma in endoscopic biopsies; additional histologic criteria for the diagnosis. Path Res Pract 2004; 200: 657-62.
38. Nauss KM, Locniskar M, Pavlina T, Newberne PM. Morphology and distribution of 1,2-dimethylhydrazine dihydrochloride- induced colon tumors and their relationship to gut-associated lymphoid tissue in the rat. J Natl Cancer Inst 1984; 73: 915-24.
39. Hardman WE, Cameron IL. Colonic crypts located over lymphoid nodules of 1,2-dimethythydrazine-treated rats are hyperplastic and at high risk of forming adenocarcinomas. Carcinogenesis 1994; 15: 2353-61.
40. Rubio CA, Nylander G, Sveander M, Duvander A, Alun ML. Minimal invasive carcinoma of the colon in rats. An J Pathol 1986; 123:161-5.
41. Ghirardi M, Nascimbeni R, Villanacci V, Fontana MG, Di Betta E, Salerni B. Azoxymethane-induced aberrant crypt foci and colorectal tumours in F344 rats: sequential analysis of growth. Eur Surg Res 1999; 31: 272-80.
42. Bissonnette M, Khare S, von Lintig FC, Wail RK, Nguyen L, Zhang Y, et al. Mutational and nonmutational activation of p21ras in rat colonic azoyxmethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1. Cancer Res 2000; 60: 4602-9.
43. Luceri C, De Filippo C, Caderni G, Gambacciani L, Salvadori M, Giannini A, et al. Detection of somatic DNA alterations in azoxymethane-induced F344 rat colon tumors by random amplified polymorphic DNA analysis. Carcinogenesis 2000; 21: 1753-6.
44. Blum CA, Tanaka T, Zhong X, Li Q, Dashwood WM, Pereira C, et al. Mutational analysis of Ctnnb1 and Ape in tumors from rats given 1,2-dimethylhydrazine or 2-amino-3-methylimidazo[4,5-f]quinoline: mutational »hotspots« and the relative expression of beta-catenin and c-jun. Mol Carcinog 2003; 36: 195-203.
45. De Filippo C, Caderni G, Bazzicalupo M, Briani C, Giannini A, Fazi M, et al. Mutations of the Ape gene in experimental colorectal carcinogenesis induced by azoxymethane in F344 rats. Br J Cancer 1998; 77: 2148-51.
46. Takahashi M, Fukuda K, Sugimura T, Wakabayashi K. Beta-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res 1998; 58: 42-6.
47. Yamada Y, Yoshimi N, Hirose Y, Kawabata K, Matsunaga K, Shimizu M, et al. Frequent ?-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance in rat colon carcinogenesis. Cancer Res 2000; 60: 3323-7.
48. Takahashi M, Mutoh M, Kawamori T, Sugimura T, Wakabayashi K. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis. Carcinogenesis 2000; 21: 1319-27.
49. De Jong TA, Skinner SA, Malcontenti-Wilson C, Vogiagis D, Bailey, van Driel IR, et al. Inhibition of rat colon tumors by sulindac and sulindac sulfone is independent of K-ras (codon 12) mutation. Am J Physiol Gastrointest Liver Physiol 2000; 278: G266-72.
50. Vivona AA, Shpitz B, Medline A, Bruce WR, Hay K, Ward MA, et al. K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis. Carcinogenesis 1993; 14: 1777-81.
51. Caderni G, Dolara P, Fazi M, Luceri C, Geido E, Rapallo A, et al. Cell cycle variantions in azoxymethane-induced rat colorectal carcinogenesis studied by flow cytometry. Oncol Rep 1999; 6: 1417-20.
52. Kishimoto Y, Morisawa T, Hosoda A, Shiota G, Kawasaki H, Hasegawa J. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane. J Exp Clin Cancer Res 2002; 21: 203-11.
53. Ehrlich VA, Huber W, Grasl-Kraupp B, Nersesyan A, Knasmuller S. Use of preneoplastic lesions in colon and liver in experimental oncology. Radiol Oncol 2004; 38: 205-16.